JB Chemicals & Pharmaceuticals Ltd. benchmarking: Performance to industry peers

Financial

	JB Chem & Pharma	Ipca Laboratories	Ajanta Pharma
Operational Metrics
Pharmaceuticals
Number of ANDA's Filed in USA	19.0 .	44.0 .	75.0 .
Number of ANDA's Approved By USFDA	17.0 .	31.0 .	56.0 .
Domestic Sales Growth - YoY	10.1 %	11.1 %	7.5 %
R&D as a % of Total Sales	1.35 %	3.12 %	5.0 %
Financials
5 yr Average ROE	19.49 %	13.55 %	21.63 %
5yr average Equity Multiplier	1.52	1.52	1.32
5yr Average Asset Turnover Ratio	0.77	0.76	0.84
5yr Avg Net Profit Margin	16.71 %	11.88 %	19.77 %
Price to Book	8.24	5.16	8.53
P/E	48.29	42.16	36.57
5yr Avg Cash Conversion Cycle	7.58 Days	54.3 Days	-102.34 Days
Inventory Days	50.33 Days	102.83 Days	55.16 Days
Days Receivable	67.54 Days	72.68 Days	49.8 Days
Days Payable	90.39 Days	111.38 Days	195.69 Days
5yr Average Interest Coverage Ratio	58.81	50.79	108.5
5yr Avg ROCE	23.05 %	17.31 %	27.48 %
5yr Avg Operating Profit Margin	24.73 %	19.8 %	27.65 %
5 yr average Debt to Equity	0.07	0.17	0.0
5yr CAGR Net Profit	8.05 %	-8.34 %	7.08 %
5yr Average Return on Assets	12.98 %	9.41 %	16.51 %
Shareholdings
Promoter Holding	48.8 %	44.72 %	66.25 %
Share Pledged by Promoters	0.0	0.0	17.94 %
Change in Promoter Holding (3 Yrs)	-5.13 %	-1.57 %	0.14 %
Change in Mutual Fund Holding (3 Yrs)	2.83 %	1.3 %	1.45 %

	JB Chem & Pharma	Ipca Laboratories	Ajanta Pharma
Product Wise Break-Up	Product Wise Break-Up Domestic Formulations 58.22 Formulations 28.73 Contract Manufacturing 10.99 Active Pharmaceutical Ingredient (API) 1.97 Generics 0 Branded Generics 0 Pharmaceutical products 0 Others 0.09	Product Wise Break-Up Formulations 0 Branded Generics 50.39 Contract Manufacturing 0 Formulations 33.08 Domestic Formulations 0 Active Pharmaceutical Ingredient (API) 0 Pharmaceutical products 0 Others 16.53	Product Wise Break-Up Formulations 0 Branded Generics 0 Contract Manufacturing 0 Generics 0 Domestic Formulations 0 Active Pharmaceutical Ingredient (API) 0 Pharmaceutical 100.0
Location Wise Break-Up	Location Wise Break-Up India 57.91 Rest of the World 42.09 Russia 0 South Africa 0 USA 0 Asia (Excluding India) 0 Australia 0 CIS 0 Africa 0 Europe 0 Asia 0	Location Wise Break-Up Russia 0 Asia 0 South Africa 0 Rest of the World 0 USA 21.58 Asia Pacific 5.18 Australia 3.2 CIS 2.91 Europe 15.68 India 44.73 Africa 6.72	Location Wise Break-Up Russia 0 Asia Pacific 19.39 South Africa 0 Rest of the World 0 USA 35.74 Asia (Excluding India) 0 Australia 0 CIS 0 Europe 0 India 28.59 Africa 16.28
Customer Wise Break-Up	Customer Wise Break-Up THINQ PHARMA-CRO PVT LTD 7.83 Others 92.17	-	-
Asset Break-Up - Segment Wise	Asset Break-Up - Segment Wise India 96.32 Others 3.68	-	-